Omalizumab in Severe Asthmatics With Food Allergy
NCT06316414
·
clinicaltrials.gov ↗
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Food; Allergy, Anaphylactic Shock
Asthma in Children
Interventions
BIOLOGICAL:
Omalizumab
Sponsor
Bambino Gesù Hospital and Research Institute